Contract notice
Section I: Contracting
authority
I.1) Name and addresses
NHS Commissioning Board (operating under the name of NHS England)
NHS England, Rutland House Second Floor,
Runcorn
WA7 2ES
UK
E-mail: michelle.clarke6@nhs.net
NUTS: UK
Internet address(es)
Main address: https://nhsengland.bravosolution.co.uk
Address of the buyer profile: https://nhsengland.bravosolution.co.uk
I.2) Joint procurement
The contract is awarded by a central purchasing body
I.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge at:
https://nhsengland.bravosolution.co.uk
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be sent electronically to:
https://nhsengland.bravosolution.co.uk
Tenders or requests to participate must be sent to the abovementioned address
I.4) Type of the contracting authority
Ministry or any other national or federal authority, including their regional or local subdivisions
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
NHS Framework Agreement for Proprietary Pharmaceuticals – Aflibercept and Ranibizumab ophthalmology products
Reference number: CM/PHR/17/5561
II.1.2) Main CPV code
33600000
II.1.3) Type of contract
Supplies
II.1.4) Short description
NHS Framework Agreement for Proprietary Pharmaceuticals – Aflibercept and Ranibizumab ophthalmology products
Offer reference number: CM/PHR/17/5561
Period of framework agreement: 1.10.2018 – 30.9.2020 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months
II.1.5) Estimated total value
Value excluding VAT:
1 220 000 000.00
GBP
II.1.6) Information about lots
This contract is divided into lots:
No
II.2) Description
II.2.3) Place of performance
NUTS code:
UKC
UKD
UKE
UKF
UKG
UKH
UKI
UKJ
UKK
Main site or place of performance:
Please refer to Schedule 8 of the Framework Agreement
II.2.4) Description of the procurement
Products associated with the lots are listed on Document Nº 05 of the Invitation to Offer Each individual National Product Code (NPC) pack description in each of the regions is deemed to be a separate product for the application of the award criteria.
There is no restriction on the number of products that bidders can offer for, or be awarded.
The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England.
The framework may also be used by private sector contractors and agents working on behalf of the above.
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Start:
01/10/2018
End:
30/09/2022
This contract is subject to renewal: No
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
Yes
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.3) Information about a framework agreement or a dynamic purchasing system
The procurement involves the establishment of a framework agreement with several operators.
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.2) Time limit for receipt of tenders or requests to participate
Date:
03/08/2018
Local time: 13:00
IV.2.4) Languages in which tenders or requests to participate may be submitted
EN
IV.2.7) Conditions for opening of tenders
Date:
03/08/2018
Local time: 13:00
Place:
Rutland House, Runcorn
Information about authorised persons and opening procedure:
Commercial Medicines Unit Employee.
Section VI: Complementary information
VI.1) Information about recurrence
This is a recurrent procurement:
No
VI.2) Information about electronic workflows
Electronic ordering will be used
Electronic invoicing will be accepted
Electronic payment will be used
VI.3) Additional information
Responding to this notice. Any supplier may be disqualified who does not respond to the following in the requisite manner:
1) Submission of expression of interest and procurement specific information. This procurement exercise will be conducted on the eTendering portal at: www.nhsengland.bravosolution.co.uk
Candidates wishing to be considered for this procurement exercise must register, and provide additional procurement specific information (if requested), through the eTendering portal as follows: 1.1) If not already registered, Candidates should register on the eTendering portal at:
https://www.nhsengland.bravosolution.co.uk and click the link to register: accept the terms and conditions and click continue, enter your correct business and user details, note the username you chose and click save when complete, you will shortly receive an email with your unique password (please keep this secure).
1.2) Once registered, candidates must express interest as follows:
a) login to the eTendering portal;
b) Select Response to ITT;
c) select ITTs Open To All Suppliers;
d) access listing related to this procurement NHS Framework Agreement for Aflibercept injection and Ranibizumab injection and view details;
e) click on Express interest button at the top of the page;
f) Once you have expressed interest, the ITT will move to My ITTs, where you can download additional documentation (if required), and construct your reply as instructed. You must then publish your reply using the Publish button.
1.3) For any support in registering on the portal or submitting your expression of interest please contact the eTendering Help-desk
At +44 800 368 4850 or: help@bravosolution.co.uk
2) General supplier information. To manage and assess supplier information the Contracting Authority requests candidates provide their company profile in the
Governments supplier information database, sid4gov, as follows:
2.1) If not already registered, Candidates must go to the following web page: https://sid4gov.cabinetoffice.gov.uk/ and select Register for sid4gov at the bottom of the page. Key in details as requested to search for your company. If you do not have a D-UN-S® Number, click on the link at the right of the page to obtain a number from D and B. Candidates must obtain a Dun and Bradstreet (D and B) D-U-N-S® Number to enable registration on sid4gov.
2.2) Once registration is complete you are able to create and update your sid4gov company profile. Candidates should ensure all the mandatory fields of their sid4gov profile are completed and up to date for each procurement exercise. D and B data will be supplied automatically by D and B.
2.3) For further help or information concerning Sid4gov, please contact the sid4gov Helpdesk at: support@nqc.com or telephone +44 (0) 845 299 2994.
The framework agreement is for the benefit of other participating NHS bodies (whether acting individually, or on behalf of, or together as members of any consortia) along with any other non-NHS bodies which the participants deem necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services. Variants: An Offerer is permitted to submit any number of variants to the Authority (subject to the minimum requirements set out in the ITO Terms of Offer Document 2, paragraph 8.2.1)
VI.4) Procedures for review
VI.4.1) Review body
NHS Commissioning Board (Operating Under the Name of NHS England)
NHS England, Rutland House, Second Floor,
Runcorn
UK
E-mail: michelle.clarke6@nhs.net
VI.5) Date of dispatch of this notice
29/06/2018